288 related articles for article (PubMed ID: 3915010)
1. Thalidomide in leprosy and some dermatological conditions--a review.
Parikh DA; Maniar JK; Ganapati R
Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
[No Abstract] [Full Text] [Related]
2. Thalidomide: an experience in therapeutic outcome and adverse reactions.
Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
[TBL] [Abstract][Full Text] [Related]
3. [Thalidomide in dermatology].
Hunziker T; Krebs A
Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
[TBL] [Abstract][Full Text] [Related]
4. [Thalidomide: a review of the literature].
dos Santos Júnior MF; Lombardi C; Belda W
Hansenol Int; 1981 Dec; 6(2):136-45. PubMed ID: 7349301
[No Abstract] [Full Text] [Related]
5. A review of thalidomide's history and current dermatological applications.
Perri AJ; Hsu S
Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide: a re-look.
Grover JK; Vats V; Gopalakrishna R; Ramam M
Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide therapy for inflammatory dermatoses.
Grosshans E; Illy G
Int J Dermatol; 1984 Nov; 23(9):598-602. PubMed ID: 6097551
[No Abstract] [Full Text] [Related]
9. Thalidomide and its dermatologic uses.
Moraes M; Russo G
Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
[TBL] [Abstract][Full Text] [Related]
10. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide: new preparation. For well-defined indications.
Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
[TBL] [Abstract][Full Text] [Related]
12. Use of thalidomide in leprosy.
Crawford CL
Adverse Drug React Toxicol Rev; 1994; 13(4):177-92. PubMed ID: 7734638
[No Abstract] [Full Text] [Related]
13. Drug survival of thalidomide for dermatological conditions: A single-centre review.
Arasu A; Lee S; Chian Yeoh A; Ross G
Australas J Dermatol; 2021 Feb; 62(1):e107-e109. PubMed ID: 32627846
[No Abstract] [Full Text] [Related]
14. [The treatment of leprosy and recurrent nodular lepromatous hypodermitis with griseofulvin].
Silva E
Dermatol Int; 1968; 7(1):37-42. PubMed ID: 5741762
[No Abstract] [Full Text] [Related]
15. New uses of thalidomide.
Med Lett Drugs Ther; 1996 Feb; 38(968):15-6. PubMed ID: 8592478
[TBL] [Abstract][Full Text] [Related]
16. Tripterygium in dermatologic therapy.
Xu WY; Zheng JR; Lu XY
Int J Dermatol; 1985 Apr; 24(3):152-7. PubMed ID: 3888878
[No Abstract] [Full Text] [Related]
17. Thalidomide--effect on T cell subsets as a possible mechanism of action.
Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
20. [Treatment of leprous reaction of the erythema nodosum type with thalidomide (N-phthalimidoglutarimide)].
Languillon J; Klein JM; Giraudeau P
Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):116-8. PubMed ID: 5713741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
